|Mr. Jose Javier Hidalgo||CEO & Director||N/A||N/A||N/A|
|Mr. Henry Batievsky||CFO & Director||N/A||N/A||N/A|
|Mr. Patrick Maloy||COO & Director||N/A||N/A||N/A|
|Dr. Jennifer McCafferty-Fernandez||Chief Science Officer||N/A||N/A||N/A|
|Mr. Jeffrey Reath||Exec. VP of Fin. & Investor Relations Corp. Sec. and Director||N/A||N/A||N/A|
Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. It operates cultivation, processing, and dispensary facilities in Florida, Texas, and Puerto Rico; and a dispensary license in Pennsylvania. The company was founded in 2015 and is headquartered in Miami, Florida.
Cansortium Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.